Wei Yow Sim’s Post

Submission Online https://lnkd.in/gqF2abyE The organizing committee for The Summit of Specialty Lenses in Rome, November 23-24, 2024, invites you to submit your abstract to the rapid-fire session on Sunday, 24th. The committee seeks topics related to specialty contact lenses and associated issues such as corneal and ocular surface diseases, dry eye, advanced technology, etc. The presentation is limited to ten minutes, followed by two minutes for Q&A. Please structure the abstract using the following standard headings: TITLE, PURPOSE, METHODS, RESULTS, and CONCLUSIONS. The abstract should be a maximum of 350 words. All research involving human subjects must be conducted in accordance with the guidelines of the Declaration of Helsinki and in adherence to applicable national and local human subject requirements, including an indication of subjects’ informed consent. The first author for selected free papers must attend the conference, and will receive a 50% discount off registration for the meeting. Daddi Fadel

What a great way to start 2025! It was a pleasure and honor to co-author the publication of phase 3 clinical trials on Vanzacaftor-tezacaftor-deutivacaftor in The Lancet Respiratory Medicine. These are great news for the #cysticfibrosis community in terms of non-inferiority compared to the currently available triple combination (ETI), once-daily dosing, improved restoration of CFTR function, and the additional in-vitro identification of 31 CFTR variants that are responsive to vanzacaftor–tezacaftor–deutivacaftor but not ETI. Claire Keating Alex Horsley https://lnkd.in/dWhsg5Vx

During GERD Awareness Week, and every week, be sure to encourage these patients to keep trying to find a treatment that works. We're proud to offer a surgical treatment option for your GERD patients that does not encircle the food passageway, which can eliminate the side effects often associated with traditional surgical procedures. Learn more at our Scientific Publications & Abstracts page: https://lnkd.in/gp3vGV3Y #GERDAwarenessWeek #ManageGERD

Thankful for the opportunity to present with Tufts Medical Center at ICCAI 2024. With significant adverse outcomes of interventions like TAVR (10% to 20% mortality at 1 year), enhanced long term risk stratification might be useful, especially in managing elderly & frail populations, optimizing outcomes and reducing waste. The conference is hosted by the Society for Complex Acute Illness. The word “complex” here is key to our narrative, as acute illness involves multiorgan dysregulation that can be seen in loss of signal complexity at multiple time scales associated with the breakdown of nonlinear regulatory feedback loops. Our results show that selected beat scales may optimize measurement of the change in information content embedded in BP waveforms (via entropy metrics) showing different cardiac contractile function and vascular systemic elastance, which variables may directly affect outcomes. Special Thanks to Ebenezer Tolman, Ethan Brovman, Sage Tuchsen, Emery Amtmann and Timothy Ruchti

Identifying Knowledge Gaps and Developing Research Priorities for Multidisciplinary Rectal and Vaginal Prolapse Care 👩⚕️ 🏥 💊 💉 For healthcare providers engaged in pelvic floor care- please take 10 minutes to complete the first survey (https://lnkd.in/dE3_drqn) to share your research ranking and priorities with us. Your responses will serve as a resource for experts to design pelvic floor research that is most impactful to your clinical practice. https://lnkd.in/dJ4JHRce

Will you be at The American Academy of Anti-Aging Medicine (A4M) in Las Vegas next weekend? We hope so—because Strive is gearing up to flip the script on personalized medicine and shake up the longevity conversation. 📍 Where to find us: Booth 7027 📅 When: December 13-15 📍 Location: Las Vegas, Nevada LongevityFest 2024 is all about redefining health and aging. Industry leaders, trailblazers, and innovators will gather to tackle big ideas and share actionable strategies for enhancing the healthspan. As we dive into topics that matter—like compounding and tailored healthcare—Strive is ready to spark some game-changing discussions. Why stop by? We’re bringing the power of custom medicine front and center. Compounding isn’t just a buzzword; it’s the future of healthcare—rigorous, personalized, and built for whole-person health. Come see how we’re striving to make better medicine a given. Let’s ignite fresh possibilities and explore how personalized healthcare can elevate longevity for every individual. 🤝 Come stop by and let's talk about compounding!

🚨BTS WINTER MEETING 2024🚨 We're thrilled to share that Dr. Hakim Ghani be presenting at the British Thoracic Society (BTS) Winter Meeting 2024 in London, where he'll be diving into an exciting and emerging topic in pulmonary vascular disease, showing how Qureight's models of pulmonary blood volumes could improve the treatment of Pulmonary Hypertension patients.  ✉️ Save the date: November 27-29, 2024, at the QEII Centre, Westminster.  🔬 Title: Quantitative Assessment of Pulmonary Artery Blood Volume in Chronic Thromboembolic Pulmonary Hypertension: Using CTPA and Machine Learning 🗣️ Session: "Crime and Punishment" in Pulmonary Vascular Disease 📅 Date: November 27, 2024 ⏰ Time: 10:45 AM 📍 Room: Rutherford, 4th Floor   Dr Ghani will be focusing on the clinical application of automated CTPA (Contrast-Enhanced CT Pulmonary Angiography) and how machine learning can provide a quantitative, accurate assessment of pulmonary vascular blood volumes. This method has the potential to revolutionize the way we approach chronic thromboembolic pulmonary hypertension (CTEPH) by providing more timely, precise, and reproducible data, allowing for better patient outcomes and treatment strategies. We're looking forward to connecting with experts, researchers, and clinicians to discuss these exciting advancements in pulmonary vascular disease! #BTSWinter2024 #CTEPH #PulmonaryHypertension #MachineLearning #MedicalInnovation #PulmonaryVascularDisease #CTPA #Healthcare #MedicalResearch #Qureight https://lnkd.in/eDASr_ud

OPEN ACCESS Article Advancements in AMA Guides Musculoskeletal Impairment Evaluations Improved Reliability and Ease of Use Melhorn, J. Mark MD; Gelinas, Barry MD; Martin, Douglas W. MD; Hegmann, Kurt T. MD; Thiese, Matthew S. PhD Journal of Occupational and Environmental Medicine 66(9):p 737-742, September 2024. | DOI: 10.1097/JOM.0000000000003145 The AMA Guides to the Evaluation of Permanent Impairment serves as the foremost guide for assessing impairment. These MSK guides are set to be updated with new methods and enhanced diagnosis-based impairment tables. It is imperative for ACOEM fellows and members to familiarize themselves with and reference these revised guides. https://lnkd.in/eXcXzqtA #JOEM

Predictive Medicine - Moving from Reaction to Proactive Care What if you could predict a patient's health trajectory and intervene before disease strikes? 🤔 Predictive medicine is turning this vision into reality. 💫 Our upcoming conference "Novel technologies for clinical application in 3P medicine" will feature expert discussions on the latest advancements in predictive diagnostics, prevention and personalisation strategies.  Discover the tools and technologies that can help you anticipate patient needs before symptoms even arise. 👉 Join us in Tivat, Montenegro, 11-12th of October to network with pioneers in 3P medicine and bring these innovations back to your practice

#FamilialHypercholesterolemia a frequent monogenic disorder causing premature ASCVD. An underdiagnosed and undertreated disorder. What's new in the management of patients with FH that can reduce CV risk ? come to #ISCP2024 in Sao Paulo and discuss about this topic. Thanks to International Society of Cardiovascular Pharmacotherapy for this opportunity